ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,262,709 | -48.8% | 274,502 | -28.1% | 0.05% | -48.4% |
| Q2 2023 | $2,465,304 | +255.4% | 381,626 | +314.8% | 0.09% | +220.7% |
| Q1 2023 | $693,680 | -69.6% | 92,000 | -60.1% | 0.03% | -67.4% |
| Q3 2022 | $2,279,000 | -21.5% | 230,400 | -15.5% | 0.09% | -28.8% |
| Q2 2022 | $2,903,000 | +19.6% | 272,612 | +9.5% | 0.12% | +20.2% |
| Q1 2022 | $2,427,000 | +213.6% | 248,900 | +360.1% | 0.10% | +112.2% |
| Q4 2021 | $774,000 | -4.8% | 54,100 | +33.4% | 0.05% | -16.9% |
| Q3 2021 | $813,000 | -68.4% | 40,547 | -65.3% | 0.06% | -76.2% |
| Q2 2021 | $2,570,000 | – | 116,800 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |